BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Innovations in Care

We provide access to support and programs that empower the lives of people living with neuromuscular diseases.

MDA Virtual Learning: OPMD

Thursday, February 29, 2024
Event Time: 4:00-5:00 EST
Live, Virtual Event

There is no cost to members of the MDA community or healthcare providers to attend the event, however registration is required. Members of the biopharma industry interested in sponsoring or attending should contact the MDA Healthcare Partnerships team at MDAPartners@mdausa.org. For all other questions, please reach out to mdaengage@mdausa.org.

Watch on Demand

This MDA webinar will provide an overview of OPMD, discuss current care and treatment approaches for OPMD, and share updates in OPMD research. There will also time for a question and answer session with the featured presenter.

The featured presenter of this webinar is Dr. Bernard Brais M.D.C.M., M.Phil., Ph.D., FRCP(C)

Neurogeneticist, Full Professor
Director of the Rare Neurological Disease Group
Neurology and Neurosurgery & Human Genetics Departments
Faculty of Medicine, McGill University

Image of a man
Dr. Bernard Brais

Not able to attend on February 29th? This webinar will be recorded for on-demand viewing. Please continue with registering even if you cannot attend to ensure you receive an email with the link to the recording. The recording will be available a few weeks after the live program.

If you have questions about this webinar or other MDA Engage programs, please reach out to mdaengage@mdausa.org or you may contact our MDA Resource Center at 1-833-ASK-MDA1 (275-6321) or ResourceCenter@mdausa.org.